Company focused on research and commercial developing of immune modulation therapies, for the treatment of cardiovascular, neurological, and other chronic inflammatory disorders.
A highly productive, intensely focused, quality-oriented CRO; experienced, well established, and driven by scientific merit.
Quebec-based pharmaceutical company. Research on chronic and neuropathic pain based on chloride ion imbalance in the spinal cord involving Kcc2.
Specialty pharmaceutical company focusing on acquisition, development, and commercialization of oncology and infectious disease products. Three late-stage products: THYMITAQ, ORATAQ and MACROTAC.
Nanotechnology research and development of antibiotic, antitumor and custom peptides.
Medical, pharmaceutical diagnostic projects using state-of-the-art pharmadiagnostic technologies.
Site contains overview of new anti-infective technology developed by the company and problems of drug resistance in general. Bacterial Transforming Agents change antibiotic-resistant bacteria, e.g. MRSA, into antibiotic-susceptible bacteria.
An independent CRO devoted to develop and implement innovative preclinical tests for drug discovery and safety pharmacology. Cardiovascular system (safety pharmacology : HERG and action potential
A medium sized R&D company located Freiburg southwest of Germany focusing on protein kinase targeted drug discovery.
Pharmaceutical manufacturing and research company committed to providing manufacturing and scientific services to the health-care industry that meet and exceed our customer's expectation of quality, while always striving for continuous improvement.
|